ENGN (enGene Therapeutics Inc. Common Stock) Stock Analysis - Politician Trades
enGene Therapeutics Inc. Common Stock (ENGN) is a publicly traded Healthcare sector company. As of May 21, 2026, ENGN trades at $1.55 with a market cap of $105.17M and a P/E ratio of 0.70. ENGN moved +5.88% today. Year to date, ENGN is -81.56%; over the trailing twelve months it is -61.67%. Its 52-week range spans $1.40 to $12.25. Analyst consensus is buy with an average price target of $8.69. Rallies surfaces ENGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded ENGN stock?
Rallies tracks politician and congressional stock disclosures for ENGN, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Rallies tracks politician and congressional stock disclosures for ENGN, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in ENGN?
Yes. Rallies tracks politician and congressional stock disclosures for ENGN, including reported purchases, sales, dates, owners, and trade amounts when available.
Is ENGN research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ENGN. It does not provide personalized investment advice.